Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Holzer, P; Painsipp, E.
Differential effects of clonidine, dopamine, dobutamine, and dopexamine on basal and acid-stimulated mucosal blood flow in the rat stomach.
CRIT CARE MED 2001 29: 335-343.
Doi: 10.1097%2F00003246-200102000-00021
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Holzer Peter
- Co-Autor*innen der Med Uni Graz
- Singewald Evelin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- OBJECTIVE: To analyze the effects of clonidine, dopamine, dobutamine, and dopexamine on gastric mucosal blood flow (GMBF) at baseline and after stimulation by acid back diffusion through a disrupted gastric mucosal barrier. DESIGN: Prospective, randomized, unblinded study. SETTING: University research laboratory. SUBJECTS: Adult Sprague-Dawley rats. INTERVENTIONS: Mean arterial blood pressure (MAP) and heart rate (HR) were recorded from a carotid artery of the phenobarbital-anesthetized animals. A jugular vein was cannulated for continuous infusion of saline and intravenous drug administration. The stomach was prepared for luminal perfusion and for recording GMBF with the hydrogen gas clearance technique. Gastric mucosal vascular conductance (GMVC) was calculated as GMBF divided by MAP. MEASUREMENTS AND MAIN RESULTS: Clonidine (37.5 and 112.5 nmol x kg(-1)) lowered MAP and HR and caused gastric vasodilation as shown by a rise of GMVC. The 2.5-fold increase in GMVC elicited by gastric perfusion with HCl (0.15 M) plus ethanol (25%) was depressed by clonidine. All cardiovascular effects of clonidine were prevented by the alpha2-adrenoceptor antagonist idazoxan (2 micromol x kg(-1)). Infusion of dopamine (15 and 45 micromol x kg(-1) x hr(-1)), dobutamine, or dopexamine (each at 5 and 15 micromol x kg(-1) x hr(-1)) caused tachycardia. GMVC at baseline was attenuated by the higher dose of dopamine and dopexamine, but not dobutamine. In contrast, the acid-induced vasodilation in the gastric mucosa was depressed by dobutamine and dopexamine, but not dopamine. CONCLUSIONS: Clonidine, dobutamine, and dopexamine at high dosage suppress the gastric mucosal vasodilator response to acid back diffusion, which is an important defense mechanism. Although the dose equivalence between rats and humans is not known, the antivasodilator effects highlight an adverse action whereby large doses of dobutamine, dopexamine, and clonidine may compromise gastric mucosal homeostasis and facilitate stress ulcer formation. Dopamine lacks this detrimental activity.
- Find related publications in this database (using NLM MeSH Indexing)
- Adrenergic alpha-Agonists - adverse effects
- Adrenergic alpha-Antagonists - pharmacology
- Adrenergic beta-Agonists - adverse effects
- Animals - adverse effects
- Blood Flow Velocity - drug effects
- Blood Pressure - drug effects
- Cardiotonic Agents - adverse effects
- Clonidine - adverse effects
- Comparative Study - adverse effects
- Dobutamine - adverse effects
- Dopamine - adverse effects
- Dopamine Agonists - adverse effects
- Drug Evaluation, Preclinical - adverse effects
- Female - adverse effects
- Gastric Acid - secretion
- Heart Rate - drug effects
- Idazoxan - pharmacology
- Infusions, Intravenous - pharmacology
- Intestinal Mucosa - blood supply
- Microcirculation - drug effects
- Prospective Studies - drug effects
- Random Allocation - drug effects
- Rats - drug effects
- Rats, Sprague-Dawley - drug effects
- Vasodilator Agents - adverse effects
- Find related publications in this database (Keywords)
- gastric mucosal blood flow
- gastric acid back diffusion
- clonidine
- idazoxan
- dopamine
- dobutamine
- dopexamine